These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26542953)

  • 1. The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland.
    Virtanen A; Anttila A; Nieminen P
    BMC Womens Health; 2015 Nov; 15():99. PubMed ID: 26542953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial.
    Virtanen A; Nieminen P; Luostarinen T; Anttila A
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1960-9. PubMed ID: 21752985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
    Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
    Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
    Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
    Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Offering Self-Sampling to Non-Attendees of Organized Primary HPV Screening: When Do Harms Outweigh the Benefits?
    Rozemeijer K; de Kok IM; Naber SK; van Kemenade FJ; Penning C; van Rosmalen J; van Ballegooijen M
    Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):773-82. PubMed ID: 25432954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-sampling HPV test in women not undergoing Pap smear for more than 5 years and factors associated with under-screening in Taiwan.
    Chou HH; Huang HJ; Cheng HH; Chang CJ; Yang LY; Huang CC; Chang WY; Hsueh S; Chao A; Wang CJ; Tang YH; Lin CT; Qiu JT; Chen MY; Chen CY; Huang KG; Tsai TC; Chang TC; Lai CH
    J Formos Med Assoc; 2016 Dec; 115(12):1089-1096. PubMed ID: 26723863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
    Aarnio R; Östensson E; Olovsson M; Gustavsson I; Gyllensten U
    BMC Cancer; 2020 Jul; 20(1):645. PubMed ID: 32660432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: Characteristics of the responders.
    Gök M; Heideman DA; van Kemenade FJ; de Vries AL; Berkhof J; Rozendaal L; Beliën JA; Overbeek L; Babović M; Snijders PJ; Meijer CJ
    Eur J Cancer; 2012 Aug; 48(12):1799-808. PubMed ID: 22172570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Self-sampling and reminder letters increase participation in the Finnish cervical cancer screening programme].
    Virtanen A; Nieminen P; Malila N; Luostarinen T; Anttila A
    Duodecim; 2013; 129(16):1709-17. PubMed ID: 24069641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving cervical cancer screening attendance in Finland.
    Virtanen A; Anttila A; Luostarinen T; Malila N; Nieminen P
    Int J Cancer; 2015 Mar; 136(6):E677-84. PubMed ID: 25178683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening.
    Darlin L; Borgfeldt C; Forslund O; Hénic E; Hortlund M; Dillner J; Kannisto P
    J Clin Virol; 2013 Sep; 58(1):155-60. PubMed ID: 23867008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
    Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
    Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for cervical cancer with the human papillomavirus test in an area of central Italy with no previous active cytological screening programme.
    Confortini M; Giorgi Rossi P; Barbarino P; Passarelli AM; Orzella L; Tufi MC
    J Med Screen; 2010; 17(2):79-86. PubMed ID: 20660436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.
    Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM
    BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
    Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
    BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
    Arbyn M; Smith SB; Temin S; Sultana F; Castle P;
    BMJ; 2018 Dec; 363():k4823. PubMed ID: 30518635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.